WO2002030321A3 - Bird diagnostics and treatments - Google Patents

Bird diagnostics and treatments Download PDF

Info

Publication number
WO2002030321A3
WO2002030321A3 PCT/US2001/031569 US0131569W WO0230321A3 WO 2002030321 A3 WO2002030321 A3 WO 2002030321A3 US 0131569 W US0131569 W US 0131569W WO 0230321 A3 WO0230321 A3 WO 0230321A3
Authority
WO
WIPO (PCT)
Prior art keywords
ort
bird
diagnostics
treatments
infection
Prior art date
Application number
PCT/US2001/031569
Other languages
French (fr)
Other versions
WO2002030321A2 (en
Inventor
Vanessa Lopes
Kakambi V Nagaraja
Original Assignee
Univ Minnesota
Vanessa Lopes
Kakambi V Nagaraja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Vanessa Lopes, Kakambi V Nagaraja filed Critical Univ Minnesota
Priority to AU2002213077A priority Critical patent/AU2002213077A1/en
Publication of WO2002030321A2 publication Critical patent/WO2002030321A2/en
Publication of WO2002030321A3 publication Critical patent/WO2002030321A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Abstract

The invention relates to methods and materials for protecting birds from infection with ORT as well as for detecting ORT infection in birds. Specifically, the invention provides ORT antigens, anti-ORT antibodies, and mutant ORT organism, as well as methods and materials for detecting and preventing ORT infections.
PCT/US2001/031569 2000-10-09 2001-10-09 Bird diagnostics and treatments WO2002030321A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002213077A AU2002213077A1 (en) 2000-10-09 2001-10-09 Bird diagnostics and treatments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23918600P 2000-10-09 2000-10-09
US60/239,186 2000-10-09

Publications (2)

Publication Number Publication Date
WO2002030321A2 WO2002030321A2 (en) 2002-04-18
WO2002030321A3 true WO2002030321A3 (en) 2003-01-30

Family

ID=22900997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/031569 WO2002030321A2 (en) 2000-10-09 2001-10-09 Bird diagnostics and treatments

Country Status (2)

Country Link
AU (1) AU2002213077A1 (en)
WO (1) WO2002030321A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107741496B (en) * 2017-09-20 2019-11-08 北京中农普康生物科技有限公司 A kind of kit and the preparation method and application thereof detecting nose tracheae bird bacillus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925361A (en) * 1992-10-14 1999-07-20 Akzo Nobel, N.V. Ornithobacterium rhinotracheale vaccines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925361A (en) * 1992-10-14 1999-07-20 Akzo Nobel, N.V. Ornithobacterium rhinotracheale vaccines

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ABSTR. CONF. RES. WORKERS ANIM. DIS. 81 MEET., vol. 3, November 2000 (2000-11-01) *
DATABASE VETU [online] DERWENT INFORMATION LTD.; LOPES ET AL.: "Development and evaluation of temperature-sensitive mutant of ornithobacterium rhinotracheale for vaccine in turkeys", XP002951951, Database accession no. 2001-61928 *
LEROY-SESTRIN ET AL.: "Genetic diversity of ornithobacterium rhinotracheale strains isolated from poultry in France", LETTERS IN APPLIED MICROBIOLOGY, vol. 26, no. 3, March 1998 (1998-03-01), pages 189 - 193 *
SPRENGER ET AL.: "Ornithobacterium rhinotracheale infection in turkeys: experimental reproduction of the disease", AVIAN DISEASES, vol. 42, 1998, pages 154 - 161 *
SPRENGER ET AL.: "Ornithobacterium rhinotracheale infection in turkeys: Immunoprophylaxis studies", AVIAN DISEASES, vol. 44, July 2000 (2000-07-01) - September 2000 (2000-09-01), pages 549 - 555, XP002951930 *

Also Published As

Publication number Publication date
AU2002213077A1 (en) 2002-04-22
WO2002030321A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
WO2001014424A3 (en) Human ctla-4 antibodies and their uses
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
CY2009014I2 (en) VACCINE AGAINST BACTERIAL ANTIGENS
WO2001000245A3 (en) HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES
WO2004006837A3 (en) Mesothelin vaccines and model systems
WO2005032582A3 (en) Immunogenic compositions for streptococcus pyogenes
WO2004058144A3 (en) Antibacterial agents
WO2004041210A3 (en) Antibacterial agents
WO2007030391A3 (en) Method for diagnosing infections
WO2001058485A3 (en) Prophylactic and therapeutic antibodies against vaccina virus antigens
BR0010418B1 (en) Salmonella microorganism, vaccine composition and use of said microorganism.
WO2002045742A8 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
WO2004091524A3 (en) Respiratory virus vaccines
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
MXPA02004942A (en) Use of anti idiotypical antibodies as vaccines against cancer.
WO2004102199A3 (en) Method for selecting and producing vaccine components and vaccines based thereon
WO2003006665A8 (en) Lawsonia intracellularis
WO2002030321A3 (en) Bird diagnostics and treatments
AU2994599A (en) Active immunization against angiogenesis-associated antigens
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
WO2001022994A3 (en) Vaccines against neisseria infection
AU2002324486A1 (en) Mutants of clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
AU2002342949A1 (en) Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other
WO2004073604A3 (en) Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
WO2004067718A3 (en) Necrosis-deficient mutants of tuberculosis bacteria

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10148139

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP